Corcept Therapeutices Eyes Another Double

 | Mar 20, 2017 | 3:03 PM EDT
  • Comment
  • Print Print
  • Print
Stock quotes in this article:


Corcept Therapeutics  (CORT) has more than doubled in the past 12 months but a look at the indicators and a Point and Figure chart suggest that CORT could double yet again from current levels. You should find the latest charts and indicators pretty convincing.

In this daily chart of CORT, below, we see CORT is above the rising 50-day moving average line and the rising 200-day moving average line. The On-Balance-Volume (OBV) line has been rising the past 12 months and tells us that buyers of CORT have been more aggressive. Notice the heavier volume of turnover since November. The Moving Average Convergence Divergence (MACD) oscillator has been above the zero line for much of the past year and is currently poised to cross to a take profits sell signal.

In this three year weekly chart of CORT, below, we can see that prices have been advancing for much of the past three years. CORT is above the rising 40-week moving average line. The weekly OBV line is bullish and the MACD oscillator is also very bullish with a fresh buy signal above the zero line.

This Point and Figure chart of CORT, below, shows an impressive base pattern. Prices broke out at $8 and have traded in a $7.00 to $11.00 range. The potential price target of this large base measures to the $22-$23 area.

Bottom line: CORT looks like it has a lot more on the upside. Traders should look to probe the long side of CORT near $10 and risk below $8.50 for now. Our upside price objective is $23.

Columnist Conversations

Although we did see an initial rally off my original CXO setup, there has been no follow through.  Some w...
on Apr 30 right here in CC, I mentioned buying the Spotify Jul 160 call. It's time to move. We have a nice ...
Some say the Diamonds are a girl's best friend. It might be a trader's best friend as our bounce zone is gett...
Today we'll be discussing a couple of important technical tools, the RSI and money flow.  Join me after t...



News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.